Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.38
+0.39 (2.17%)
At close: Oct 28, 2025, 4:00 PM EDT
18.51
+0.13 (0.71%)
Pre-market: Oct 29, 2025, 9:07 AM EDT
Avalo Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$30.14
Upside
+63.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +117.63% | Sep 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $25 | Strong Buy | Maintains | $15 → $25 | +36.02% | Sep 17, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | -18.39% | Jun 2, 2025 |
| Jefferies | Jefferies | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +25.14% | Mar 25, 2025 |
| Stifel | Stifel | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +95.87% | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 20, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +161.15% | Feb 28, 2025 |
| BTIG | BTIG | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +117.63% | Dec 19, 2024 |
| LUCID CAPITAL MARKETS | LUCID CAPITAL MARKETS | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +30.58% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 24, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $35 | Hold → Buy | Upgrades | $35 | +90.42% | Apr 16, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $2,160 → $180 | Buy → Hold | Downgrades | $2,160 → $180 | +879.33% | Jun 27, 2023 |
| RBC Capital | RBC Capital | Buy Maintains $4,080 → $2,160 | Buy | Maintains | $4,080 → $2,160 | +11,651.90% | May 10, 2023 |
| Jefferies | Jefferies | Hold → Sell Downgrades $720 | Hold → Sell | Downgrades | $720 | +3,817.30% | Feb 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.